Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 25:9:956500.
doi: 10.3389/fmolb.2022.956500. eCollection 2022.

Regulation and physiological functions of phoenixin

Affiliations
Review

Regulation and physiological functions of phoenixin

Han Liang et al. Front Mol Biosci. .

Abstract

Phoenixin is a newly discovered neuropeptide generated from small integral membrane protein 20. Phoenixin is a ligand for the G protein-coupled receptor 173 (GPR173) and has been detected in central and peripheral tissues of human, rats, mice, bovine, and zebrafish. It was initially involved in regulating reproductive function by stimulating the luteinizing hormone release from pituitary cells by increasing the level of gonadotropin-releasing hormone. Recently, many functions of phoenixin have been generalized, including regulation of food intake, memory, Alzheimer's disease, anxiety, inflammation, neuronal and microglial activity, energy metabolism and body fluid balance, cardiovascular function, and endocrine activity. In addition, the interaction between phoenixin and nesfatin-1 have been revealed. The present article summarized the latest research progress on physiological function of phoenixin, suggesting that it is a potential target for novel drug development and clinical application.

Keywords: GPR173; inflammation; nesfatin-1; phoenixin; reproduction.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
The physiological and pathological roles of phoenixin. AHA, Anterior hypothalamic area; Akt, protein kinase B; AMPK, AMP-activated protein kinase; ATF4, activating transcription factor 4; AVP, arginine vasopressin; cAMP, cyclic adenosine monophosphate; C/EBP, CCAAT/enhancer binding protein; CREB, cAMP-response element binding protein; CRF1/CRF2, corticotropin-releasing factor 1/2; CCK, cholecystokinin; E2, estradiol; eIF-2α, eukaryotic translation initiation factor 2α; eNOS, endothelial nitric oxide synthase; ERK, extracellular signal-related kinase; FSH, follicle-stimulating hormone; FSI, fasting serum insulin; GH, growth hormone; GhRH-R, growth hormone-releasing hormone receptor; GnRH, gonadotropin-releasing hormone; GnRH-R, gonadotropin-releasing hormone receptor; GOAT, ghrelin-O-acyl transferase; HAECs, human aortic endothelial cells; HFD, high-fat diet; HMGB1, high mobility group box1; HO-1, heme oxygenase-1; ICAM-1, intercellular adhesion molecule-1; IL-1β, interleukin-1β; IL-8, interleukin-8; LH, luteinizing hormone; LPS, lipopolysaccharide; MCP-1, monocyte chemotactic protein-1; Myd88, myeloid differentiation primary response 88; NF-κB, nuclear factor-κB; NLRP3, NOD-like receptor protein 3; NOX-4, NADPH oxidase 4; NPY1, neuropeptide Y1; NPY5, neuropeptide Y5; NRF2, Erythroid 2-related factor 2; NST, nucleus of the solitary tract; Oct-1, octamer-binding transcription factor-1; OT, oxytocin; ox-LDL, oxidized low-density lipoprotein; PCOS, polycystic ovary syndrome; PKA, protein kinase A; PGC-1α, peroxisome-proliferator-activated receptor coactivator (PGC)-1α; ROS, reactive oxygen species; SIRT1, Sirtuin1; TLR4, toll-like receptor 4; VCAM-1, vascular cell adhesion molecule-1; VSMCs, vascular smooth muscle cells; Δψm; mitochondrial membrane potential.

References

    1. Acconcia F., Pallottini V., Marino M. (2015). Molecular mechanisms of action of BPA. Dose. Response. 13, 1559325815610582. 10.1177/1559325815610582 - DOI - PMC - PubMed
    1. Ademoglu E. N., Gorar S., Carlıoglu A., Yazıcı H., Dellal F. D., Berberoglu Z., et al. (2014). Plasma nesfatin-1 levels are increased in patients with polycystic ovary syndrome. J. Endocrinol. Invest. 37, 715–719. 10.1007/s40618-014-0089-2 - DOI - PubMed
    1. Billert M., Kołodziejski P. A., Strowski M. Z., Nowak K. W., Skrzypski M. (2019). Phoenixin-14 stimulates proliferation and insulin secretion in insulin producing INS-1E cells. Biochim. Biophys. Acta. Mol. Cell. Res. 1866, 118533. 10.1016/j.bbamcr.2019.118533 - DOI - PubMed
    1. Billert M., Rak A., Nowak K. W., Skrzypski M. (2020). Phoenixin: More than reproductive peptide. Int. J. Mol. Sci. 21, 8378. 10.3390/ijms21218378 - DOI - PMC - PubMed
    1. Billert M., Wojciechowicz T., Jasaszwili M., Szczepankiewicz D., Wasko J., Kazmierczak S., et al. (2018). Phoenixin-14 stimulates differentiation of 3T3-L1 preadipocytes via cAMP/Epac-dependent mechanism. Biochim. Biophys. Acta. Mol. Cell. Biol. Lipids 1863, 1449–1457. 10.1016/j.bbalip.2018.09.006 - DOI - PubMed

LinkOut - more resources